Ingrid Ricard
About
Ingrid Ricard is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine.
According to data from OpenAlex, Ingrid Ricard has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Ingrid Ricard's work include Colorectal Cancer Treatments and Studies (15 papers), Gastric Cancer Management and Outcomes (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Ingrid Ricard is often cited by papers focused on Colorectal Cancer Treatments and Studies (15 papers), Gastric Cancer Management and Outcomes (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Ingrid Ricard collaborates with scholars based in Germany, Switzerland and United States. Ingrid Ricard's co-authors include Volker Heinemann, Dominik Paul Modest, Sebastian Stintzing, Julian Walter Holch, A. C. Davison, Ted C. J. Turlings, Dirk Arnold, Ullrich Graeven, Arndt Stahler and Thomas Kirchner and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Clinical Cancer Research.
In The Last Decade
Ingrid Ricard
23 papers receiving 1.1k citations
Hit Papers
Peers
Ingrid Ricard
Sarah J. Kennedy United States
Marzena Zdanowicz United States
Feng Jin China
Jingchun Yang United States
Dennis J. Chia United States
Victoria Parker United Kingdom
Nicolas Jacquelot Australia
Lamis Yehia United States
Gordon J. Allan United Kingdom
Shuhong Liu China
Citations per year, relative to Ingrid Ricard Ingrid Ricard (= 1×)
peers
Sarah J. Kennedy
Countries citing papers authored by Ingrid Ricard
Since
Specialization
Citations
This map shows the geographic impact of Ingrid Ricard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Ricard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Ricard more than expected).
Fields of papers citing papers by Ingrid Ricard
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ingrid Ricard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Ricard. The network helps show where Ingrid Ricard may publish in the future.
Co-authorship network of co-authors of Ingrid Ricard
This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Ricard. A scholar is included among the top collaborators of Ingrid Ricard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Ricard. Ingrid Ricard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Heinrich, Kathrin, Dominik Paul Modest, Ingrid Ricard, et al.. (2021). Gender-dependent survival benefit from first-line irinotecan in metastatic colorectal cancer. Subgroup analysis of a phase III trial (XELAVIRI-study, AIO-KRK-0110). European Journal of Cancer. 147. 128–139.
2.
Stahler, Arndt, Sebastian Stintzing, Dominik Paul Modest, et al.. (2020). Amphiregulin Expression Is a Predictive Biomarker for EGFR Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials. Clinical Cancer Research. 26(24). 6559–6567.
3.
Vöglein, Jonathan, Ingrid Ricard, Soheyl Noachtar, et al.. (2020). Seizures in Alzheimer’s disease are highly recurrent and associated with a poor disease course. Journal of Neurology. 267(10). 2941–2948.
4.
Stahler, Arndt, Volker Heinemann, Ingrid Ricard, et al.. (2020). Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials. Journal of Cancer Research and Clinical Oncology. 146(8). 2077–2087.
5.
Liu, Lian, Nicole Erickson, Julian Walter Holch, et al.. (2020). Effect of weight loss in patients with metastatic colorectal cancer treated within the randomized phase III FIRE-3 trial (AIO KRK 0306).. Journal of Clinical Oncology. 38(4_suppl). 87–87.
6.
Modest, Dominik Paul, Volker Heinemann, Gunnar Folprecht, et al.. (2020). Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306. Annals of Surgical Oncology. 27(7). 2389–2401.
7.
Vöglein, Jonathan, Ingrid Ricard, Soheyl Noachtar, et al.. (2019). P2‐297: EPILEPSY IN ALZHEIMER DISEASE IS FREQUENT AND CHARACTERIZED BY HIGH RECURRENCE. Alzheimer s & Dementia. 15(7S_Part_13).
8.
Modest, Dominik Paul, Ingrid Ricard, Kathrin Heinrich, et al.. (2019). Gender and survival benefit from initial irinotecan in metastatic colorectal cancer: Analysis of the XELAVIRI (AIOKRK0110) study.. Journal of Clinical Oncology. 37(4_suppl). 549–549.
9.
Stintzing, Sebastian, Ingrid Ricard, Andreas Jung, et al.. (2018). Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients—Analysis of the Phase III AIO KRK-0207 Trial. Frontiers in Oncology. 8. 474–474.
10.
Holch, Julian Walter, Volker Heinemann, Ingrid Ricard, et al.. (2018). Prognostic value of radiologically enlarged lymph nodes in patients with metastatic colorectal cancer: Subgroup findings of the randomized, open-label FIRE-3/AIO KRK0306 trial. European Journal of Radiology. 100. 124–129.
11.
Holch, Julian Walter, Ingrid Ricard, Sebastian Stintzing, et al.. (2018). Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial). European Journal of Cancer. 106. 115–125.
12.
Modest, Dominik Paul, Timm Denecke, Johann Pratschke, et al.. (2017). Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer—central evaluation of FIRE-3. European Journal of Cancer. 88. 77–86.
13.
Jochheim, David, Ingrid Ricard, Hans Theiß, et al.. (2017). Predictors of cerebrovascular events at mid-term after transcatheter aortic valve implantation – Results from EVERY-TAVI registry. International Journal of Cardiology. 244. 106–111.
14.
Modest, Dominik Paul, Ingrid Ricard, Sebastian Stintzing, et al.. (2017). Evaluation of survival across several treatment lines in metastatic colorectal cancer: Analysis of the FIRE-3 trial (AIO KRK0306). European Journal of Cancer. 84. 262–269.
15.
Modest, Dominik Paul, Ingrid Ricard, Volker Heinemann, et al.. (2016). Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group. Annals of Oncology. 27(9). 1746–1753.
16.
Modest, Dominik Paul, Ingrid Ricard, Volker Heinemann, et al.. (2016). Influence of KRAS exon 2 mutation variants as well as NRAS- and BRAF-mutations on outcome of patients with metastatic colorectal cancer (mCRC) receiving combination chemotherapy with or without bevacizumab.. Journal of Clinical Oncology. 34(15_suppl). 3551–3551.
17.
Holch, Julian Walter, Ingrid Ricard, Sebastian Stintzing, Dominik Paul Modest, & Volker Heinemann. (2016). The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials. European Journal of Cancer. 70. 87–98.
18.
Kaiser, Christoph, S. Galatius, Paul Erné, et al.. (2010). Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries. New England Journal of Medicine. 363(24). 2310–2319.
19.
Ricard, Ingrid, et al.. (2010). Effects of Rewarding and Unrewarding Experiences on the Response to Host-induced Plant Odors of the Generalist Parasitoid Cotesia marginiventris (Hymenoptera: Braconidae). Journal of Insect Behavior. 23(4). 303–318.
20.
Ricard, Ingrid. (2008). Statistical methods for insect choice experiments. Infoscience (Ecole Polytechnique Fédérale de Lausanne).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Sarah J. Kennedy Breakdown of academic impact, for papers by Marzena Zdanowicz Breakdown of academic impact, for papers by Feng Jin Breakdown of academic impact, for papers by Jingchun Yang Breakdown of academic impact, for papers by Dennis J. Chia Breakdown of academic impact, for papers by Victoria Parker Breakdown of academic impact, for papers by Nicolas Jacquelot Breakdown of academic impact, for papers by Lamis Yehia Breakdown of academic impact, for papers by Gordon J. Allan Breakdown of academic impact, for papers by Shuhong Liu